Skip to main content

Grafa News and Videos — Page 1047

Grafa Headlines

Latest

Grafa

BioCryst highlights efficacy gains across hereditary angioedema portfolio

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported new clinical trial data and supportive real-world evidence evaluating its hereditary angioedema (HAE) portfolio at the European Academy of Allergy and Clinical Immunology (EAACI) 2026 Annual Meeting in Istanbul, Turkey.

Read more: BioCryst highlights efficacy gains across hereditary angioedema portfolio
Grafa
Technology

Vertiv finalizes ThermoKey acquisition to scale thermal infrastructure for AI buildouts

Vertiv Holdings (NYSE:VRT) has finalized its acquisition of ThermoKey, a specialized European manufacturer of heat-rejection and heat-exchange systems, directly expanding its critical digital infrastructure portfolio.

Read more: Vertiv finalizes ThermoKey acquisition to scale thermal infrastructure for AI buildouts

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift